BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18313512)

  • 1. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
    Ramritu P; Halton K; Collignon P; Cook D; Fraenkel D; Battistutta D; Whitby M; Graves N
    Am J Infect Control; 2008 Mar; 36(2):104-17. PubMed ID: 18313512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
    Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
    JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
    Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
    Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
    Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
    León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
    Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
    J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.
    Raad I; Darouiche R; Dupuis J; Abi-Said D; Gabrielli A; Hachem R; Wall M; Harris R; Jones J; Buzaid A; Robertson C; Shenaq S; Curling P; Burke T; Ericsson C
    Ann Intern Med; 1997 Aug; 127(4):267-74. PubMed ID: 9265425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review.
    Gilbert RE; Harden M
    Curr Opin Infect Dis; 2008 Jun; 21(3):235-45. PubMed ID: 18448967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
    Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
    Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
    Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
    Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are antiseptic-coated central venous catheters effective in a real-world setting?
    Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S
    Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.
    Raad I; Mohamed JA; Reitzel RA; Jiang Y; Raad S; Al Shuaibi M; Chaftari AM; Hachem RY
    Antimicrob Agents Chemother; 2012 Feb; 56(2):935-41. PubMed ID: 22123686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
    Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
    Raad I; Darouiche R; Hachem R; Mansouri M; Bodey GP
    J Infect Dis; 1996 Feb; 173(2):418-24. PubMed ID: 8568304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision.
    Halton KA; Cook DA; Whitby M; Paterson DL; Graves N
    Crit Care; 2009; 13(2):R35. PubMed ID: 19284570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.